Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histone Deacetylase Inhibitor”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Testing effectiveness (Phase 2)Study completedNCT01680094
What this trial is testing

Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART

Who this might be right for
HIV Infection
University of Aarhus 15
Large-scale testing (Phase 3)WithdrawnNCT02654405
What this trial is testing

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Who this might be right for
Schizophrenic DisordersCognitive Function
Nathan Kline Institute for Psychiatric Research
Testing effectiveness (Phase 2)Ended earlyNCT01528501
What this trial is testing

Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)

Who this might be right for
Metastatic Gastric Cancer
Technical University of Munich 28
Testing effectiveness (Phase 2)Study completedNCT02471430
What this trial is testing

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV Infection
Massachusetts General Hospital 17
Early research (Phase 1)Study completedNCT00015925
What this trial is testing

MS-275 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Ended earlyNCT00496431
What this trial is testing

PhII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients

Who this might be right for
Hodgkin's Lymphoma
Italfarmaco 19
Large-scale testing (Phase 3)WithdrawnNCT03010865
What this trial is testing

Sodium Butyrate For Improving Cognitive Function In Schizophrenia

Who this might be right for
Schizophrenic DisorderCognitive Impairment
Shanghai Mental Health Center
Testing effectiveness (Phase 2)Ended earlyNCT01188707
What this trial is testing

A Trial of Belinostat in Combination With Erlotinib in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Herlev Hospital 5
Early research (Phase 1)Study completedNCT01463046
What this trial is testing

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaAdvanced Myelodysplastic Syndrome
University of California, San Francisco 29
Testing effectiveness (Phase 2)Study completedNCT03770000
What this trial is testing

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Who this might be right for
T Cell Lymphoma
Rhizen Pharmaceuticals SA 33
Large-scale testing (Phase 3)UnknownNCT02902185
What this trial is testing

Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir

Who this might be right for
Chronic HIV Infections
Tang-Du Hospital 60
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00867672
What this trial is testing

Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
University Hospital Freiburg 204
Early research (Phase 1)Study completedNCT00101179
What this trial is testing

MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+5 more
National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)UnknownNCT01298934
What this trial is testing

LBH589 (Panobinostat) for the Treatment of Myelofibrosis

Who this might be right for
Primary MyelofibrosisPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePost-Essential Thrombocythemia Related Myelofibrosis
Ronald Hoffman 22
Testing effectiveness (Phase 2)Study completedNCT02588339
What this trial is testing

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Who this might be right for
Graft Versus Host DiseaseGVHD
H. Lee Moffitt Cancer Center and Research Institute 42
Testing effectiveness (Phase 2)Study completedNCT03382834
What this trial is testing

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Testing effectiveness (Phase 2)WithdrawnNCT03873025
What this trial is testing

CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
University College, London
Not applicableUnknownNCT03515915
What this trial is testing

Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

Who this might be right for
Patients With Recurrent or Refractory Multiple Myeloma
University Hospital, Montpellier 30
Testing effectiveness (Phase 2)Study completedNCT00289952
What this trial is testing

Valproic Acid and Its Effects on HIV Latent Reservoirs

Who this might be right for
HIV Infections
Jean-Pierre Routy 50
Load More Results